5 Canadian Cannabis Stocks with Superior Growth Prospects

The Canadian cannabis stocks on our list have exhibited operational excellence based on Q/Q and Y/Y grams sold along with revenue growth

SmallCapPower | May 22, 2018: As legalization approaches, cannabis companies must compete for supply agreements and retail space. Statistics Canada estimated Canadians consumed 770t of cannabis in 2017, with 94% of that consumption for recreational purposes. Companies increasing their production and sales to meet demand could capture a strong retail presence early on. The Canadian cannabis stocks on our list today have released their financial results recently, giving investors insight into their production and revenue increases.

Cronos Group Inc. (TSXV:CRON) – $7.57
Cannabis

Cronos Group is a licensed producer of medical marijuana under the ACMPR. The Company produces marijuana primarily out of its Peace Naturals facilities, which have a production capacity of 6,650 kg/year, with construction of a 286,000 sq. ft. facility with a production capacity of 33,500 kg/year expected to be completed by the summer of 2018. Cronos holds four joint ventures for distribution of the MedMen brand in Canadian retail stores, products for indigenous communities, and production facilities in Australia and Israel.

  • Market Cap: $1,333.9 Million
  • Last EPS Report Date: 5/15/2018
  • Grams Sold, Q/Q: N/A
  • Grams Sold, Y/Y: 672.0%
  • Revenue, Q/Q: 82.9%
  • Revenue, Y/Y: 473.2%
  • Return since Report Date: -8.4%

CannTrust Holdings Inc. (TSX:TRST) – $8.82
Cannabis

CannTrust is a Canada-based licensed producer of medical cannabis. The Company’s products are sold online and delivered to registered patients. CannTrust’s original 50,000 square foot production facility located in Vaughan, Ontario uses hydroponic technology to produce at an annual capacity of 3,600 KG. Furthermore, CannTrust has set aside a 46-acre property, where it plans to add capacity with a 430,000-square foot expansion.

  • Market Cap: $810.5 Million
  • Last EPS Report Date: 5/15/2018
  • Grams Sold, Q/Q: 29.6%
  • Grams Sold, Y/Y: 195.4%
  • Revenue, Q/Q: 13.7%
  • Revenue, Y/Y: 233.2%
  • Return since Report Date: -15.4%

Aurora Cannabis Inc. (TSX:ACB) – $7.20
Cannabis

Aurora Cannabis is a licensed producer and seller of medical marijuana and cannabis oil under the ACMPR. The Company operates three production facilities with a total capacity of 15,800kg. Currently, the Company is engaged in the construction of its new 800,000 sq. ft. production facility in Alberta, called Aurora Sky. On May 14, Aurora announced the acquisition of MedReleaf (TSX:LEAF) for $3.2B in stock.

  • Market Cap: $4,045.6 Million
  • Last EPS Report Date: 5/8/2018
  • Grams Sold, Q/Q: 16.5%
  • Grams Sold, Y/Y: 107.2%
  • Revenue, Q/Q: 37.6%
  • Revenue, Y/Y: 211.1%
  • Return since Report Date: -11.2%

Organigram Holdings Inc. (TSXV:OGI) – $4.65
Cannabis

Organigram is a Canada-based marijuana producer operating in New Brunswick. The Company currently produces 22,000 kg/year out of its 134,000 sq. ft. facility. OGI plans to expand this facility, increasing production to 65,500 kg by April 2019 and 113,000 kg by April 2020. The Company has signed Memorandums of Understanding with New Brunswick and Prince Edward Island to supply cannabis to the recreational market.

  • Market Cap: $579.5 Million
  • Last EPS Report Date: 4/24/2018
  • Grams Sold, Q/Q: 21.8%
  • Grams Sold, Y/Y: 67.8%
  • Revenue, Q/Q: 14.6%
  • Revenue, Y/Y: 155.2%
  • Return since Report Date: 16.0%

Aphria Inc. (TSX:APH) – $11.89
Cannabis

Aphria is a licensed producer and supplier of medical marijuana under the ACMPR. Aphria’s flagship greenhouse production facility is located on a 169-acre property in Leamington, Ontario. The Company currently produces 9,000kg and plans to expand its production facility to add an additional 90,000kg.

  • Market Cap: $2,497.0 Million
  • Last EPS Report Date: 4/16/2018
  • Grams Sold, Q/Q: 15.4%
  • Grams Sold, Y/Y: 118.8%
  • Revenue, Q/Q: 20.7%
  • Revenue, Y/Y: 100.6%
  • Return since Report Date: 4.3%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: